Lecanemab, Eisai and Biogen’s experimental anti-amyloid Alzheimer’s drug, which recently wrapped its Phase 3 clinical trials, continues to make the news. Some of these…
The majority of experimental Alzheimer’s drugs are being designed to halt the progression of the disease — a strategy which so far has yielded…
The approval of the controversial anti-amyloid drug Aduhelm last year marked a major milestone for Alzheimer’s research — it became the first new drug…
Could insulin treat Alzheimer’s the same way it treats diabetes? Evidence shows Alzheimer’s might be more similar to a metabolic disorder, like diabetes, than…
Hello from the CTAD Alzheimer’s research conference in San Francisco, where I am attending this year’s meeting on the latest announcements on Alzheimer’s disease…
Update 27 January, 2023: In January 2023, lecanemab was granted accelerated approval by the FDA and made available to patients under the brand name…
Mild cognitive impairment (MCI), the condition associated with early stages of Alzheimer’s disease and related forms of dementia (like vascular dementia or Lewy Body…
Can a virus lead to Alzheimer’s disease? Alzheimer’s expert Ruth Itzhaki at the University of Oxford reflects on a career dedicated to one of…
They’ve been studying the same group of people for 76 years. This is what they’ve learned about Alzheimer’s disease… so far. Psychology in epidemiology…
Most Alzheimer’s treatments on the market today help manage symptoms, like memory loss — but they don’t get at the root cause. Roche hoped their…
Lapses in memory are a fairly normal part of healthy aging. But in the early stages of neurodegenerative diseases like Alzheimer’s dementia, cognitive changes…
Research shows two of every five cases of Alzheimer’s and related dementias are preventable. According to credible, peer-reviewed scientific studies, here are the 8…
Researchers in Tokyo continue encouraging research on oxytocin as a potential Alzheimer’s drug target. When administered nasally, the hormone appeared to reverse cognitive decline…
Donald Weaver, a researcher and physician who acts as co-director at the Krembil Brain Institute, provides evidence that Alzheimer’s is a result of the…
Ever since German physician Alois Alzheimer first described the disease in 1906, scientists have searched for the root cause of Alzheimer’s. Though the most…